<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/SearchAction>
<http://www.genengnews.com/gen-news-highlights/bayer-s-regorafenib-met-primary-pfs-endpoint-in-late-stage-gist-trial/81246849/?kwrd=Bayer>